Suggested guidelines for the diagnosis and management of urea cycle disorders
about
Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disordersUrea cycle disorders: a case report of a successful treatment with liver transplant and a literature reviewProposed guidelines for the diagnosis and management of methylmalonic and propionic acidemiaHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsFrequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD)On the Creation, Utility and Sustaining of Rare Diseases Research Networks: Lessons learned from the Urea Cycle Disorders Consortium, the Japanese Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type MetabolicKinetic mutations in argininosuccinate synthetase deficiency: characterisation and in vitro correction by substrate supplementationPediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012.Switch from Sodium Phenylbutyrate to Glycerol Phenylbutyrate Improved Metabolic Stability in an Adolescent with Ornithine Transcarbamylase DeficiencyExpanding the phenotype in argininosuccinic aciduria: need for new therapies.Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland.Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case report.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Psychiatric adult-onset of urea cycle disorders: A case-series.A zebrafish model of hyperammonemia.Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.Glutamine and hyperammonemic crises in patients with urea cycle disorders.Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatmentThe hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.Functional characterization of the spf/ash splicing variation in OTC deficiency of mice and man.Liver transplantation for metabolic liver disease: experience at a living donor dominant liver transplantation center.Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration.Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patientsSimple and inexpensive quantification of ammonia in whole blood.Evaluation of Implementation, Adaptation and Use of the Recently Proposed Urea Cycle Disorders GuidelinesNetworking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium.Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetateAlteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegiaAnesthetic experience of an adult male with citrullinemia type II: a case report.A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemiaComputational modeling to predict nitrogen balance during acute metabolic decompensation in patients with urea cycle disorders.Refeeding syndrome in a young woman with argininosuccinate lyase deficiencyProtein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate.Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational studyGuidelines for acute management of hyperammonemia in the Middle East region.Intracranial Pressure Monitoring Demonstrates that Cerebral Edema Is Not Correlated to Hyperammonemia in a Child with Ornithine Transcarbamylase DeficiencyOrnithine transcarbamylase deficiency combined with type 1 diabetes mellitus - a challenge in clinical and dietary management.Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
P2860
Q26771677-08D53235-1EB9-488C-ABD8-49962A12A21BQ26852486-A3A6DE1D-06EF-4957-A23E-8FD8636FA4D9Q26865440-6E686C8C-3EA5-4A0B-B925-B6F63D4928F1Q28392199-BC225580-4BF3-48D5-807A-623DA0F2B6EAQ28600855-F1C64FF1-E70E-4C8C-BB3B-1CFAE9E50CFBQ28602731-3A3DCDA6-831D-41F7-8C2A-FA04E927E5E7Q29147513-5D52429D-E5CA-409E-8F42-73928013E973Q30679633-A814CB2C-DFCB-49E3-86EC-B37087313A7DQ33554824-37A7E319-1C58-4A37-97B9-72036B4367C3Q33569530-D1052A6F-DF65-4980-8D30-AA818FC369A3Q33707443-ACFCA729-DAEF-4D87-B4CA-3CD6189BE58AQ33805398-DC4F2453-E0C3-4E0F-B2D8-F68F625DA39CQ33879846-1615E74C-ADAC-4E77-9D8F-22A2E89952BBQ33881920-F8922762-DF51-4082-AEFE-9CB3CEE53201Q33887237-0712AB4C-7215-4631-BF72-7BBD9CB91D62Q34314609-134E54AF-7773-4AF0-963C-3DEA3B3D798EQ34377810-DBD65F5F-43CE-4E04-A92C-2BD8CC797818Q34502317-0BC42F9A-75D6-43AF-A1E0-720A101C5EAAQ34645366-500BF885-9BCC-457D-8C3D-4A64C4A03DE5Q35004859-141C7DAD-5A6C-49A4-8643-924B014A7EDFQ35174229-8452551B-BED3-4FF6-902A-11801D33A7E4Q35327051-2FEFBEBB-D969-4E45-BAD8-9C90B2A7CADBQ35348585-BCE782FE-ADE4-4C6B-BCFA-607A72BBF1F9Q35530609-6E4D1153-424E-4D3F-84F1-70380C87D15FQ35645704-D371D086-5C9E-4D20-BD6A-1B4D395A7F11Q35711384-1D3E98D1-61DB-4829-A4EA-FF37173ECF34Q35752453-B1B5D2DB-1B81-4408-A35A-EED98A0735FEQ35800998-62DEA3EE-60E5-44F6-ADAD-A13699222653Q36001522-44EB2455-55EB-4006-9FD9-79CC177CF61FQ36008185-3A0D0EB1-3922-4050-A823-A9BF8ABC2306Q36159588-263A896E-CFB2-41EA-8DB5-379358AC1084Q36210311-C3A6A010-6D9E-4CB6-AD6E-D4E0050016A2Q36463770-BFCB94E8-8892-4187-A419-92DF6CCFAEB1Q36571552-5EF872FB-1ADC-4F13-8C76-3C26A10E5927Q36680649-CB2CB957-92CC-499C-9480-6538A3D019FFQ36748949-2E959F61-0599-4CFF-95A6-9E2D5BFE1EF4Q36763624-60C5DF01-5040-4ED4-93F9-AD78E12A26BFQ36895300-C81A909D-680F-4BA5-8C87-8238ACCD910AQ36996717-8AA771F4-1D87-48C7-8990-1A168CD4F96BQ37189404-D71A64AD-5B84-424E-9DD1-851A38B3BA96
P2860
Suggested guidelines for the diagnosis and management of urea cycle disorders
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Suggested guidelines for the diagnosis and management of urea cycle disorders
@ast
Suggested guidelines for the diagnosis and management of urea cycle disorders
@en
Suggested guidelines for the diagnosis and management of urea cycle disorders
@en-gb
Suggested guidelines for the diagnosis and management of urea cycle disorders
@nl
type
label
Suggested guidelines for the diagnosis and management of urea cycle disorders
@ast
Suggested guidelines for the diagnosis and management of urea cycle disorders
@en
Suggested guidelines for the diagnosis and management of urea cycle disorders
@en-gb
Suggested guidelines for the diagnosis and management of urea cycle disorders
@nl
prefLabel
Suggested guidelines for the diagnosis and management of urea cycle disorders
@ast
Suggested guidelines for the diagnosis and management of urea cycle disorders
@en
Suggested guidelines for the diagnosis and management of urea cycle disorders
@en-gb
Suggested guidelines for the diagnosis and management of urea cycle disorders
@nl
P2093
P2860
P50
P3181
P356
P1476
Suggested guidelines for the diagnosis and management of urea cycle disorders
@en
P2093
Alberto Burlina
Anupam Chakrapani
Diego Martinelli
Johannes Häberle
Marjorie Dixon
Martin Lindner
Pablo Sanjurjo Crespo
René Santer
P2860
P2888
P3181
P356
10.1186/1750-1172-7-32
P407
P50
P5008
P577
2012-05-29T00:00:00Z
P5875
P6179
1007881252